Medindia

X

Vanrx Pharmasystems to launch SA25 Aseptic Filling Workcell to the Indian pharmaceutical market at P-MEC 2016

Tuesday, November 8, 2016 Indian Health News J E 4
Advertisement

VANCOUVER, British Columbia, Nov. 8, 2016 /PRNewswire/ -- Vanrx Pharmasystems, a manufacturer of advanced sterile filling solutions for the pharmaceutical industry, will launch its SA25 Aseptic Filling Workcell into the Indian market at P-MEC India 2016.

Vanrx will be exhibiting in Hall 7, Stand S13, which takes place from 21-23 November 2016 at the Bombay Exhibition Centre. Visitors to the stand can see the Workcell operating in a 360-degree virtual reality video experience. The company will also distribute its new whitepaper, titled "A New Paradigm for Manufacturing Injectable Medicines" which details the workcell approach and how it benefits production flexibility and quality.

The SA25 Aseptic Filling Workcell is the world's first gloveless robotic isolator for fill-finish of injectable (parenteral) drug products. The Workcell uses robotics to perform all material handling, filling and container closing activities. It was designed by pharmaceutical veterans who wanted to solve long-standing aseptic processing problems in conventonal fill-finish systems. Their goal was to make the production of complex drug products easier and improve patient safety.

"Companies that take advantage of the technological advancements provided by the SA25 Workcell will bring their drug products to market faster and beat their competition, achieving superior market share and profitability. Vanrx has its first major customer in India and hopes to meet more companies who want to build world-class manufacturing operations at P-MEC India," said Chris Procyshyn, CEO and co-founder of Vanrx Pharmasystems.

A major generic pharmaceutical company recently installed a Vanrx Workcell at its Indian production facilities. The Workcell is an excellent fit for the Indian market, with its emphasis on generics, biosimilars and contract manufacturing. Its flexibility to fill vials, syringes or cartridges enables the production of a wide range of drug products on a single machine.

Key benefits of the SA25 Workcell include:

  • Capability to fill and close vials, syringes or cartridges on the same machine, with industry-leading quality;
  • Enables efficient production of multiple products through fast changeover and batch cycling times;
  • Shortens time to construct filling operations or add capacity through a standardized design;
  • Lowers costs by using less space and requiring fewer utilities than conventional systems;
  • Use of nested components and closures simplifies material handling and minimizes particle generation.

Interested companies can contact Vanrx to arrange a meeting at P-MEC India or from 24 November to 2 December 2016, following the exhibition.

About Vanrx Pharmasystems

Vanrx Pharmasystems makes the most technologically advanced sterile filling solutions for the pharmaceutical industry. Vanrx fill-finish machines use isolated robotics and machine vision to automate the packaging of injectable drugs into nested vials, syringes, or cartridges. The company was founded by pharmaceutical industry veterans to create the systems needed to make the next generation of innovative therapies. For more information, visit www.vanrx.com.

Contact Vanrx

To schedule media interviews or request a meeting, please contact:

Eric PetzSenior Marketing ManagerVanrx PharmasystemsPhone: +1.604.453.8660 ext. 773

GRAPHIC: SA25 Workcell picture

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
India bans Cruel Eye & Skin Test on Rabbits for Dr...
S
Partnerships and Innovation: Shaping the Future of...